JNPMEDI attends the "66th Autumn Academic Conference of the Korean Society of Cardiology " and presents the "The Future of Decentralized Clinical Trials (DCTs)."

KSC 2022

The three-day conference will be held in an on-site event from September 23 to 25 and is the largest event in the second half of the year for the Korean Society of Cardiology. About 2,500 domestic and global attendees in the field of cardiology will participate.

Kwun-ho Jung, CEO of JNPMEDI, presenting on the afternoon of the 23rd under the theme of Connected Health, will introduce the recently increasing number of decentralized clinical trials. The presentation will provide insights on the rapid shift toward a patient-centered medical paradigm and suggest ways to apply them in Korea.

JNPMEDI is an IT company that captures and monitors clinical data to derive analysis through the "Maven Clinical Data Management System (CDMS)" solution.

In the wake of the COVID-19 pandemic, decentralized clinical trial services, which have emerged as an alternative to traditional clinical trials, are digitally transforming the pharmaceutical and medical sectors, bringing change to conservative industry.

Meanwhile, the Korean Society of Cardiology, founded in 1957, is an affiliated organization of the Korean Medical Association and holds an international academic conference every year to improve and develop circulatory science and is considered the best academic organization in Korea.